Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $33.42B | $28.19B | +18.57% |
Cost of Revenue | $12.86B | $8.45B | +52.15% |
Operating Income | $7.26B | $7.9B | -8.09% |
Net Income | $4.09B | $6.72B | -39.11% |
EPS (Basic) | $7.62 | $12.56 | -39.33% |
EPS (Diluted) | $7.56 | $12.49 | -39.47% |
SG&A Expense | $7.1B | $6.18B | +14.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $91.84B | $97.15B | -5.47% |
Current Assets | $29.03B | $30.33B | -4.29% |
Current Liabilities | $23.1B | $18.39B | +25.59% |
Stockholders' Equity | $5.88B | $6.23B | -5.70% |
Cash & Equivalents | $11.97B | $10.94B | +9.40% |
Long-Term Debt | $60.1B | $64.61B | -6.99% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $11.49B | $8.47B | +35.64% |
Investing Cash Flow | $-1.05B | $-26.2B | +96.01% |
Financing Cash Flow | $-9.41B | $21.05B | -144.73% |
Share Buybacks | $200M | $0 | — |
D&A | $5.59B | $4.07B | +37.36% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 21.7% | 28.0% | -6.30% |
Net Margin | 12.2% | — | — |
ROE | 69.6% | — | — |
ROA | 4.5% | — | — |
Current Ratio | $1.257 | — | — |
Other companies in Biotechnology